Santosh Kesari, MD, PhD

Affiliate Faculty

Director Neuro-Oncology, Pacific Neuroscience Institute; Professor of Neurosciences and Chair, Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, Providence Saint John's Health Center

Santosh Kesari, MD, PhD, is a board-certified neurologist and neuro-oncologist. A physician and scientist, Dr. Kesari specializes in personalized medicine for patients with malignant brain tumors. His experience in precision therapeutic strategies targets brain tumors at the molecular level to eradicate the disease. Dr. Kesari’s research efforts have focused on cancer stem cells, their role in the formation of brain tumors and their resistance to treatment. His goal is to advance neurological medicine by developing targeted drugs to eradicate brain tumors. He has more than 200 publications, including original articles, reviews, editorials, books and clinical communications. Dr. Kesari has received countless awards and recognition throughout his medical career, and he was named one of America’s Top Doctors by Castle Connolly. He is a world leader in the innovative treatment of all types of malignant brain tumors. He and his team conduct leading-edge clinical trials in immunotherapy and biomarker-based brain tumor therapies.

For more information, visit:

• Glioblastoma
• Metastatic brain cancers
• Paraneoplastic syndromes
• Leptomeningeal metastases
• Immunotherapy

MD, University of Pennsylvania School of Medicine, Philadelphia, PA
PhD, Molecular Biology, University of Pennsylvania School of Medicine, Philadelphia, PA
Residency, Neurology, Massachusetts General Hospital / Brigham and Women’s Hospital / Harvard Medical School, Boston, MA
Fellowship, Neuro-Oncology, Dana-Farber Cancer Institute / Massachusetts General Hospital, Boston, MA
Board Certified, Neuro-Oncology and Neurology
FANA – Fellow of the American Neurological Association
FAAN – Fellow of the American Academy of Neurology